Eve & Co Inc., - CEO, Melinda Rombouts
CEO, Melinda Rombouts
Source: O’Cannabiz
Market Herald logo


Be the first with the news that moves the market
  • Eve & Co (TSXV:EVE) subsidiary Natural MedCo has received its European Union “Good Manufacturing Practice” certification
  • The Government of Upper Bavaria in Germany granted the certification
  • Natural MedCo is one of only a few Canadian companies with a EU GMP certification for cannabis
  • Eve & Co’s share price is up 36.84 per cent, and is currently trading at $0.13 per share

Female-led cannabis company Eve & Co (TSXV:EVE) has announced that its subsidiary, Natural MedCo, has received EU GMP certification.

The European Union ‘Certificate of GMP Compliance of a Manufacturer” was granted by the Government of Upper Bavaria in Germany.

GMP (Good Manufacturing Practice) certification is an essential stamp of approval that Natural MedCo had to obtain in order to start fulfilling supply agreements.

The company made great efforts to ensure that its manufacturing standards, production practices, and products were consistently high-quality. Company employees also had to have an adequate amount of experience in order to meet the standard.

Having satisfied EU GMP requirements, Natural MedCo is one of the few Canadian companies with EU GMP certification for cannabis. It almost certainly has the first Canadian female-led cannabis facility with an EU GMP certification.

Eve & Co President and CEO, Melinda Rombouts, said she was very happy with the achievement.

“I attribute this accomplishment to the hard work of our team and their dedication to ensuring our facility complies with the most stringent standards. This certification enables us to continue in our global growth strategy and fulfil contracts in the EU market,” she said. 

“With our 1 million square foot licensed greenhouse, we hope to set ourselves apart as one of the largest cannabis facilities in the world. We will also do so with our ability to distribute our products in a much larger global marketplace, “Melinda added.

Eve & Co’s share price is up 36.84 per cent, and is trading at $0.13 per share, as of 1:04pm EST.

More From The Market Herald

Buzz on the Bullboards: Has the November rally paid off?

In the past week, the energy sector has been leading downward pressure on Canada’s main stock index as crude oil prices continued to fall.

Canopy Growth’s new CBD gummies follow cannabis wellness trend

Canopy Growth is debuting a new line of Martha Stewart CBD gummies set to benefit from a consumer shift to cannabis wellness solutions.

What is going on with Canopy Growth stock?

Canopy Growth (TSX:WEED) stock has had a tumultuous trading history and investors want to know if is a good buy for their portfolios today.

Shiny Health appoints interim CEO after Nadeau’s resignation

Shiny Health & Wellness has appointed Meris Kott as the cannabis company's interim CEO after the resignation of Michael Nadeau.